249 related articles for article (PubMed ID: 23233170)
61. Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells.
Yan X; Ke XX; Zhao H; Huang M; Hu R; Cui H
Mol Med Rep; 2015 Feb; 11(2):791-6. PubMed ID: 25354591
[TBL] [Abstract][Full Text] [Related]
62. Inhibition of interleukin-13 gene expression by triptolide in activated T lymphocytes.
Dai S; Yin K; Yao X; Zhou L
Respirology; 2013 Nov; 18(8):1249-55. PubMed ID: 23796028
[TBL] [Abstract][Full Text] [Related]
63. [Effects of triptolide on proliferation and apoptosis of Jurkat cell line in acute T lymphocytic leukemia].
Yao GH; Luan JF; Ye D; Yan JM; Lei QH; Zhu PY; Jin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):506-9. PubMed ID: 18549618
[TBL] [Abstract][Full Text] [Related]
64. Casticin Induces DNA Damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells.
Huang AC; Cheng YD; Huang LH; Hsiao YT; Peng SF; Lu KW; Lien JC; Yang JL; Lin TS; Chung JG
Anticancer Res; 2019 Apr; 39(4):1839-1847. PubMed ID: 30952724
[TBL] [Abstract][Full Text] [Related]
65. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms.
Kuo CY; Chou WC; Wu CC; Wong TS; Kakadiya R; Lee TC; Su TL; Wang HC
Oncotarget; 2015 Sep; 6(28):25770-83. PubMed ID: 26208482
[TBL] [Abstract][Full Text] [Related]
66. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
[TBL] [Abstract][Full Text] [Related]
67. Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells.
Li J; Liu R; Yang Y; Huang Y; Li X; Liu R; Shen X
Oncol Rep; 2014 May; 31(5):2181-6. PubMed ID: 24676587
[TBL] [Abstract][Full Text] [Related]
68. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells.
Yinjun L; Jie J; Yungui W
Leuk Res; 2005 Jan; 29(1):99-105. PubMed ID: 15541481
[TBL] [Abstract][Full Text] [Related]
69. The genetic depletion or the triptolide inhibition of TFIIH in p53-deficient cells induces a JNK-dependent cell death in Drosophila.
Villicaña C; Cruz G; Zurita M
J Cell Sci; 2013 Jun; 126(Pt 11):2502-15. PubMed ID: 23549790
[TBL] [Abstract][Full Text] [Related]
70. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
[TBL] [Abstract][Full Text] [Related]
71. Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.
Yao C; Li H; Zhang W
Int J Immunopathol Pharmacol; 2018; 32():2058738418812349. PubMed ID: 30453799
[TBL] [Abstract][Full Text] [Related]
72. Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells.
Zhao F; Chen Y; Zeng LL; Li R; Zeng R; Wen L; Liu Y; Zhang C
Acta Pharmacol Sin; 2010 Jun; 31(6):733-40. PubMed ID: 20523343
[TBL] [Abstract][Full Text] [Related]
73. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies.
Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE
Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205
[TBL] [Abstract][Full Text] [Related]
74. Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA.
Vispé S; DeVries L; Créancier L; Besse J; Bréand S; Hobson DJ; Svejstrup JQ; Annereau JP; Cussac D; Dumontet C; Guilbaud N; Barret JM; Bailly C
Mol Cancer Ther; 2009 Oct; 8(10):2780-90. PubMed ID: 19808979
[TBL] [Abstract][Full Text] [Related]
75. Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation.
Zhao F; Huang W; Ousman T; Zhang B; Han Y; Clotaire DZ; Wang C; Chang H; Luo H; Ren X; Lei M
PLoS One; 2013; 8(11):e80784. PubMed ID: 24244715
[TBL] [Abstract][Full Text] [Related]
76. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
[TBL] [Abstract][Full Text] [Related]
77. Enhanced anti-tumor activity of triptolide in combination with irradiation for the treatment of oral cancer.
Chen YW; Lin GJ; Hueng DY; Huang SH; Chia WT; Shieh YS; Ma KH; Sytwu HK
Planta Med; 2014 Mar; 80(4):255-61. PubMed ID: 24510366
[TBL] [Abstract][Full Text] [Related]
78. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
[TBL] [Abstract][Full Text] [Related]
79. Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro.
Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z
Tumour Biol; 2017 Apr; 39(4):1010428317697556. PubMed ID: 28381158
[TBL] [Abstract][Full Text] [Related]
80. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
